Zischke, for example, uses mass spectrometry. The postdoctoral researcher from the Institute of Virology is looking for new substances that are effective against the carcinogenic Kaposi Sarcoma Herpesvirus
rer. nat. Beate Sodeik Medizinische Hochschule Hannover (Hannover Medical School) Institute of Virology, OE5230 Carl-Neuberg-Str. 1 30625 Hannover Phone +49 511 532 2846 Departmental Secretary +49 511 [...] "), she became Assistant Professor in 2002, and Associate Professor in 2007 at the Institute of Virology at Hannover Medical School. Alumni of the Group Richardo, Timmy - Dr. rer. nat., Predoctoral Scientist
School (MHH) has all the benefits of a structured PhD program, which include training in Immunology, Virology, Microbiology, as well as critical thinking and science communication to the public. The program
(Director: Prof. Dr. H. Hof, Heidelberg University) 02/97 M.D. specialisation in Medical Microbiology, Virology and Epidemiology of Infectious Diseases 05/92-02/97 Resident physician and Research Group Leader
of the history of HBV research Hans L Tillmann (Greenville, USA) 18:15-18:35 Introduction to HBV virology – what’s this cccDNA? Prof. Joe Torresi (Melbourne, Australia) 18:40-19:00 HBV management – challenges [...] Biotechnology Dr. rer. nat. Daniel Todt Ruhr-Universität Bochum (RUB) Department of Molecular & Medical Virology Prof. Dr. med. Heiner Wedemeyer Hannover Medical School (MHH) Department of Gastroenterology, Hepatology
Christine Falk , Head of the Institute of Transplantation Immunology: Review Board Microbiology, Virology, Immunology, Subject 2.21-05 Immunology Professor Dr Frank Bengel , Director of the Clinic for Nuclear
the study programme together with you," said Prof. Dr. Thomas Schulz, head of the MHH Institute of Virology and spokesperson of the RESIST Cluster of Excellence, at the opening ceremony on 7 October. He is
Department for Virology and Immunology at the German Primate Center (DPZ) in Göttingen, Germany 2004 to 2007 PhD in the working group „BSE - Risk assessment” in the Department for Virology and Immunology [...] analysis, , genome editing using designer nucleases TALEN and CRISPR/Cas9), cell culture techniques virological methods and handling of pathogens of security level BSL 1 to 3 (“Umgangsgenehmigung nach IfSG §44”)
spokesperson of the cluster of excellence is Professor Dr. Thomas Schulz, head of the MHH Institute of Virology. More information is available here: www.RESIST-cluster.de Further information is available to
smallest detail. RESIST spokesperson is Professor Dr. Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG). For more information about the RESIST